CBLL vs IRTC
CBLL: Ceribell develops wearable EEG systems and AI-powered software for rapid, automated seizure detection and brain monitoring in acute care settings. IRTC: A leading digital health company that detects and monitors cardiac arrhythmias using a wearable ECG patch and cloud analytics platform, enabling faster diagnosis than traditional monitoring methods.
Side-by-side fundamentals
| Metric | CBLL | IRTC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $16.82 | $106.07 | |
| Market cap as of 2026-07-23 | $638M | $3.5B | |
| Net margin as of 2026-07-23 | -63.5% | -3.5% | IRTC higher |
| Gross margin as of 2026-07-23 | +87.7% | +71.0% | CBLL higher |
| Operating margin as of 2026-07-23 | -68.3% | -5.2% | IRTC higher |
| ROE as of 2026-07-23 | -38.2% | -20.6% | IRTC higher |
| ROA as of 2026-07-23 | -30.9% | -2.8% | IRTC higher |
| Debt / equity as of 2026-07-23 | 0.14 | 4.03 | CBLL lower |
| Revenue growth (YoY) as of 2026-07-23 | +29.3% | +27.4% | CBLL higher |
| Revenue CAGR (3y) SEC XBRL | +40.3% | +22.1% | CBLL higher |
| Beta as of 2026-07-23 | 0.79 | 1.33 | |
| 1-year return as of 2026-07-22 close | +17.6% | -20.5% | CBLL higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.